Christine Ring - 09 Aug 2022 Form 4 Insider Report for Nurix Therapeutics, Inc. (NRIX)

Role
General Counsel
Signature
/s/ Christine Ring
Issuer symbol
NRIX
Transactions as of
09 Aug 2022
Net transactions value
$0
Form type
4
Filing time
10 Aug 2022, 16:19:45 UTC
Previous filing
02 Aug 2022
Next filing
01 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NRIX Employee Stock Option (right to buy) Award $0 +40,199 $0.000000 40,199 09 Aug 2022 Common Stock 40,199 $18.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/48 of the total shares monthly beginning September 9, 2022 until the option is fully vested on August 9, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.